Human umbilical cord-derived mesenchymal stem cell therapy (Children's Hospital of Chongqing Medical University)

人脐带间充质干细胞疗法（重庆医科大学附属儿童医院）

Report date: 2024/11/13 20:00:43

Base Information

Drug NameHuman umbilical cord-derived mesenchymal stem cell therapy (Children's Hospital of Chongqing Medical University)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derived

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsBronchopulmonary Dysplasia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaPending

Originator CompaniesChildren’S Hospital Of Chongqing Medical University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesChildren’S Hospital Of Chongqing Medical University

Active IndicationsN/A

Inactive IndicationsBronchopulmonary Dysplasia

Other Information

ATC CodeN/A